Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus.

about

Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus.

Item

http://www.wikidata.org/entity/Q48130954

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Use of sodium-glucose cotransp ...... with type 2 diabetes mellitus.

@en

Use of sodium-glucose cotransp ...... with type 2 diabetes mellitus.

@nl

type

Item

label

Use of sodium-glucose cotransp ...... with type 2 diabetes mellitus.

@en

Use of sodium-glucose cotransp ...... with type 2 diabetes mellitus.

@nl

prefLabel

Use of sodium-glucose cotransp ...... with type 2 diabetes mellitus.

@en

Use of sodium-glucose cotransp ...... with type 2 diabetes mellitus.

@nl

P1476

Use of sodium-glucose cotransp ...... with type 2 diabetes mellitus

@en

P2093

Hiroshi Asano

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Osanai

http://www.w3.org/2001/XMLSchema#string

Kazuyoshi Sakai

http://www.w3.org/2001/XMLSchema#string

Masayoshi Ajioka

http://www.w3.org/2001/XMLSchema#string

Takahiro Kambara

http://www.w3.org/2001/XMLSchema#string

Toyoaki Murohara

http://www.w3.org/2001/XMLSchema#string

Yoshihito Nakashima

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

10-year follow-up of intensive glucose control in type 2 diabetes

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Pleiotropic effects of type 2 diabetes management strategies on renal risk factors.

Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trials

Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice

P304

108-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/GGI.13149

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rei Shibata

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28861952

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes